Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05HXX
|
|||
| Former ID |
DAP000199
|
|||
| Drug Name |
Tranexamic Acid
|
|||
| Synonyms |
AMCA; AMCHA; AMH; Amikapron; Amstat; Anvitoff; Carxamin; Cyclocapron; Cyklokapron; Emorhalt; Exacyl; Frenolyse; Hexapromin; Hexatron; Mastop; Rikavarin; Spiramin; Tamcha; Tranex; Tranexamsaeure; Tranexan; Transamin; Transamlon; Trasamlon; Ugurol; Acide tranexamique; Acido tranexamico; Acidum tranexamicum; Tranexmic acid; Tranhexamic acid; Trans AMCHA; CL 65336; DV 79; DV79; KABI 2161; LT00159441; ALBB-006013; Acide tranexamique [INN-French]; Acido tranexamico [INN-Spanish]; Acidum tranexamicum [INN-Latin]; CL-65336; Cis-AMCHA; Cyklokapron (TN); DV-79; RP 18,429; Rikavarin (TN); Rikavarin-S; T-AMCHA; Tranexamic acid cis-form; Trans-Amcha; Trans-Tranexamic acid; Cis-4-(Aminomethyl)cyclohexanecarboxylic acid; Tranexamic acid (JP15/USAN/INN); Tranexamic acid [USAN:INN:BAN:JAN]; Trans-4-(Aminomethyl)cyclohexanecarboxylic acid; Trans-4-(Aminomethyl)cyclohexanecarboxylic acid ester; Trans-p-(Aminomethyl)cyclohexanecarboxylic; Trans-p-(Aminomethyl)cyclohexanecarboxylic acid; Cis-4-Aminomethylcyclohexane-1-carboxylic acid; Trans-1-Aminomethylcyclohexane-4-carboxylic acid; Trans-4-(Aminomethyl)cyclohexane-carboxylic acid; Trans-4-Aminomethylcyclohexane-1-carboxylic acid; Trans-1-(Aminomethyl)cyclohexane-4-carboxylic acid; Trans-4-(Aminomethyl)-1-cyclohexanecarboxylic acid; Trans-4-(Aminomethyl)cyclohexane-1-carboxylic acid; 4-(Aminomethyl)-Cyclohexanecarboxylic Acid; 4-(Aminomethyl)cyclohexanecarboxylic acid; 4-(aminomethyl)cyclohexane-1-carboxylic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Excessive bleeding [ICD-11: GA30.02; ICD-10: N92.4; ICD-9: 459] | Approved | [1], [2] | |
| Therapeutic Class |
Antifibrinolytic Agents
|
|||
| Company |
Daiichi Sankyo Pharma Development
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H15NO2
|
|||
| Canonical SMILES |
C1CC(CCC1CN)C(=O)O
|
|||
| InChI |
1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)
|
|||
| InChIKey |
GYDJEQRTZSCIOI-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 701-54-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
145436, 224560, 582925, 3139692, 5659223, 7848199, 7885862, 7980823, 8149799, 8153401, 10321473, 11112474, 11335830, 11361069, 11364285, 11366847, 11369409, 11372436, 11373650, 11377571, 11462041, 11466199, 11467319, 11484425, 11485718, 11488471, 11491004, 11491861, 11495205, 14747988, 15321700, 16459820, 24846186, 24888448, 25630628, 26612264, 26679310, 26703794, 26748579, 26748580, 29224568, 37101809, 41863959, 46391649, 46508089, 47291131, 47440254, 47521547, 47588995, 47662284
|
|||
| ChEBI ID |
CHEBI:48669
|
|||
| ADReCS Drug ID | BADD_D02261 | |||
| SuperDrug ATC ID |
B02AA02
|
|||
| SuperDrug CAS ID |
cas=001197188
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6573). | |||
| REF 2 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 019281. | |||
| REF 3 | Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation. J Thromb Haemost. 2007 Oct;5(10):2113-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.